HRSA Releases 340B Insulin Final Rule Over Health Centers’ Strong Objections

The U.S. Health Resources and Services Administration (HRSA) this morning released a final rule to implement the Trump administration’s controversial executive order requiring community health centers to pass their 340B program savings on insulin and epinephrine autoinjectors to low-income, uninsured, and underinsured patients.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.